Published in PLoS One on March 24, 2010
Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09
The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69
Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol (2013) 4.10
Host lifestyle affects human microbiota on daily timescales. Genome Biol (2014) 2.99
Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study. J Clin Endocrinol Metab (2015) 2.82
Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 2.72
Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One (2010) 2.60
Meta-analyses of studies of the human microbiota. Genome Res (2013) 2.35
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut (2012) 2.10
Genomic approaches to studying the human microbiota. Nature (2012) 2.00
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85
The human microbiome and its potential importance to pediatrics. Pediatrics (2012) 1.74
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70
High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother (2012) 1.69
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics (2015) 1.56
Integrating next-generation sequencing and traditional tongue diagnosis to determine tongue coating microbiome. Sci Rep (2012) 1.52
Signatures of early frailty in the gut microbiota. Genome Med (2016) 1.47
'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol (2013) 1.45
Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma. PLoS One (2016) 1.44
Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences. Eur J Clin Invest (2012) 1.43
Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis (2011) 1.42
Spatial Variation of the Gut Microbiota in Broiler Chickens as Affected by Dietary Available Phosphorus and Assessed by T-RFLP Analysis and 454 Pyrosequencing. PLoS One (2015) 1.42
The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol (2017) 1.40
Antibiotics and the gut microbiota. J Clin Invest (2014) 1.39
Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J (2014) 1.38
The human microbiome: ecosystem resilience and health. Nutr Rev (2012) 1.30
Proton pump inhibitors alter the composition of the gut microbiota. Gut (2015) 1.28
Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis (2015) 1.27
Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) (2014) 1.25
The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control (2012) 1.24
Normal neonatal microbiome variation in relation to environmental factors, infection and allergy. Curr Opin Pediatr (2012) 1.23
Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome. Front Microbiol (2013) 1.17
Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol (2011) 1.17
Defining the human microbiome. Nutr Rev (2012) 1.15
Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med (2016) 1.14
Role of the normal gut microbiota. World J Gastroenterol (2015) 1.12
Short-term effect of antibiotics on human gut microbiota. PLoS One (2014) 1.12
Species identification and profiling of complex microbial communities using shotgun Illumina sequencing of 16S rRNA amplicon sequences. PLoS One (2013) 1.09
Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One (2013) 1.09
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med (2016) 1.08
Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax (2013) 1.08
Genome sequencing reveals a phage in Helicobacter pylori. MBio (2011) 1.05
Food and human gut as reservoirs of transferable antibiotic resistance encoding genes. Front Microbiol (2013) 1.04
Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes. Gut Microbes (2013) 1.02
Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol (2011) 1.01
Modeling the impact of antibiotic exposure on human microbiota. Sci Rep (2014) 1.01
Pyrosequencing as a tool for better understanding of human microbiomes. J Oral Microbiol (2012) 1.01
Defining the "core microbiome" of the microbial communities in the tonsils of healthy pigs. BMC Microbiol (2012) 1.00
Temporal and technical variability of human gut metagenomes. Genome Biol (2015) 1.00
Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls. PeerJ (2015) 0.99
Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy. PLoS One (2013) 0.98
Predominant effect of host genetics on levels of Lactobacillus johnsonii bacteria in the mouse gut. Appl Environ Microbiol (2011) 0.98
The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol (2013) 0.97
The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97
Structural and functional changes in the gut microbiota associated to Clostridium difficile infection. Front Microbiol (2014) 0.97
The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol (2013) 0.97
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes (2013) 0.97
Comparative digestive physiology. Compr Physiol (2013) 0.96
Strategies to minimize antibiotic resistance. Int J Environ Res Public Health (2013) 0.96
Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Analysis of the American Gut Project. EBioMedicine (2014) 0.95
In silico analysis of antibiotic resistance genes in the gut microflora of individuals from diverse geographies and age-groups. PLoS One (2013) 0.93
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. Ann Neurol (2015) 0.93
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS (2014) 0.92
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol (2014) 0.91
Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes. Infect Drug Resist (2014) 0.91
Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. J Infect Dis (2015) 0.91
Microbial regulation of allergic responses to food. Semin Immunopathol (2012) 0.90
Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis. J Pediatr (2015) 0.90
Differences in metabolites of different tongue coatings in patients with chronic hepatitis B. Evid Based Complement Alternat Med (2013) 0.90
Molecular and cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol (2016) 0.90
Application of microarray and functional-based screening methods for the detection of antimicrobial resistance genes in the microbiomes of healthy humans. PLoS One (2014) 0.89
Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia. J Clin Immunol (2011) 0.89
Upper gastrointestinal microbiota and digestive diseases. World J Gastroenterol (2013) 0.89
Recurrent antibiotic exposure may promote cancer formation - Another step in understanding the role of the human microbiota? Eur J Cancer (2015) 0.88
Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults. PLoS One (2016) 0.88
16S rRNA terminal restriction fragment length polymorphism for the characterization of the nasopharyngeal microbiota. PLoS One (2012) 0.88
Antibiotic use and childhood body mass index trajectory. Int J Obes (Lond) (2015) 0.87
The Infant Microbiome: Implications for Infant Health and Neurocognitive Development. Nurs Res (2015) 0.87
Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int J Mol Sci (2014) 0.87
Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs. BMC Vet Res (2015) 0.85
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism. PLoS One (2015) 0.85
Antibiotics and the developing infant gut microbiota and resistome. Curr Opin Microbiol (2015) 0.85
The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis (2016) 0.84
Synthetic RNA silencing in bacteria - antimicrobial discovery and resistance breaking. Front Microbiol (2011) 0.84
The chemical interactome space between the human host and the genetically defined gut metabotypes. ISME J (2012) 0.84
Expansion of Microbial Forensics. J Clin Microbiol (2016) 0.84
Development of the infant intestinal microbiome: A bird's eye view of a complex process. Birth Defects Res C Embryo Today (2015) 0.84
Early life triclocarban exposure during lactation affects neonate rat survival. Reprod Sci (2014) 0.83
Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection. PLoS One (2015) 0.83
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor. Antimicrob Agents Chemother (2015) 0.83
The microbiota, the immune system and the allograft. Am J Transplant (2014) 0.83
Use of the Microbiome in the Practice of Epidemiology: A Primer on -Omic Technologies. Am J Epidemiol (2015) 0.83
Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health (2014) 0.82
Ancient human microbiomes. J Hum Evol (2015) 0.82
Natural transformation of an engineered Helicobacter pylori strain deficient in type II restriction endonucleases. J Bacteriol (2012) 0.82
Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) (2015) 0.82
Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2016) 0.82
Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice. Front Immunol (2017) 0.81
Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study. Gut Liver (2016) 0.81
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol (1993) 51.00
Diversity of the human intestinal microbial flora. Science (2005) 49.64
16S ribosomal DNA amplification for phylogenetic study. J Bacteriol (1991) 47.78
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
Bacterial community variation in human body habitats across space and time. Science (2009) 24.84
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res (2006) 16.26
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Defining the normal bacterial flora of the oral cavity. J Clin Microbiol (2005) 15.75
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr (1995) 13.30
Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol (1998) 10.67
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol (1998) 8.56
Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A (2006) 7.77
Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A (2004) 5.64
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology (2007) 5.04
Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol (2000) 4.49
Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis (2001) 4.17
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J (2007) 3.92
Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol (1995) 3.77
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med (2003) 3.04
Bacterial contributions to mammalian gut development. Trends Microbiol (2004) 3.03
Regular review: treatment of Helicobacter pylori infection. BMJ (2000) 2.73
Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett (2008) 2.12
Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (1994) 1.85
Enteric flora in health and disease. Digestion (2006) 1.70
Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J Microbiol Methods (2003) 1.54
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother (1999) 1.52
Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother (2000) 1.48
Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother (2006) 1.40
Therapy of Helicobacter pylori: current status and issues. Gastroenterology (2000) 1.32
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment. Scand J Infect Dis (2007) 1.27
Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Appl Environ Microbiol (2005) 1.21
Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother (1992) 1.18
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. Antimicrob Agents Chemother (2002) 1.15
Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin. Emerg Infect Dis (2005) 1.10
Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria. BMC Microbiol (2009) 1.03
Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Aliment Pharmacol Ther (2001) 0.96
Clarithromycin treatment selects for persistent macrolide-resistant bacteria in throat commensal flora. Int J Antimicrob Agents (2005) 0.91
Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques. J Med Microbiol (2005) 0.81
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
DNA Probe Method for the Detection of Specific Microorganisms in the Soil Bacterial Community. Appl Environ Microbiol (1988) 13.80
Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09
Deep-sea oil plume enriches indigenous oil-degrading bacteria. Science (2010) 6.73
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol (2010) 4.52
Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol (2011) 4.10
Community-wide analysis of microbial genome sequence signatures. Genome Biol (2009) 3.96
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J (2007) 3.92
Metagenomic analysis of a permafrost microbial community reveals a rapid response to thaw. Nature (2011) 3.80
Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology (2010) 3.68
Shotgun metaproteomics of the human distal gut microbiota. ISME J (2008) 3.43
Transitions in bacterial communities along the 2000 km salinity gradient of the Baltic Sea. ISME J (2011) 3.33
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med (2003) 3.04
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Tackling soil diversity with the assembly of large, complex metagenomes. Proc Natl Acad Sci U S A (2014) 2.65
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
The Earth Microbiome project: successes and aspirations. BMC Biol (2014) 2.58
Metagenome, metatranscriptome and single-cell sequencing reveal microbial response to Deepwater Horizon oil spill. ISME J (2012) 2.45
Meta-analyses of studies of the human microbiota. Genome Res (2013) 2.35
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13
Microbial gene functions enriched in the Deepwater Horizon deep-sea oil plume. ISME J (2011) 2.10
Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut (2013) 2.04
Interactions between arbuscular mycorrhizal fungi and bacteria and their potential for stimulating plant growth. Environ Microbiol (2006) 1.88
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog (2006) 1.68
Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol (2006) 1.64
Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol (2009) 1.64
Soft inertial microfluidics for high throughput separation of bacteria from human blood cells. Lab Chip (2009) 1.63
Community proteogenomics highlights microbial strain-variant protein expression within activated sludge performing enhanced biological phosphorus removal. ISME J (2008) 1.60
Deep-sea bacteria enriched by oil and dispersant from the Deepwater Horizon spill. Environ Microbiol (2012) 1.58
Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. Eur J Gastroenterol Hepatol (2008) 1.42
Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother (2006) 1.40
Novel primers for 16S rRNA-based archaeal community analyses in environmental samples. J Microbiol Methods (2010) 1.38
Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A (2008) 1.37
Antimicrobial resistance in campylobacter: susceptibility testing methods and resistance trends. J Microbiol Methods (2013) 1.32
Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infect Immun (2003) 1.32
Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol (2006) 1.31
Impact of phenolic substrate and growth temperature on the Arthrobacter chlorophenolicus proteome. J Proteome Res (2009) 1.31
Nitrogenase gene amplicons from global marine surface waters are dominated by genes of non-cyanobacteria. PLoS One (2011) 1.27
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment. Scand J Infect Dis (2007) 1.27
A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol (2005) 1.26
Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int J Syst Evol Microbiol (2005) 1.26
Titration-free massively parallel pyrosequencing using trace amounts of starting material. Nucleic Acids Res (2010) 1.25
Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice. Am J Physiol Gastrointest Liver Physiol (2006) 1.23
Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl Environ Microbiol (2007) 1.23
Concordance of Helicobacter pylori strains within families. J Clin Microbiol (2003) 1.22
Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One (2013) 1.21
Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol (2005) 1.21
Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Appl Environ Microbiol (2005) 1.21
Active nitrogen-fixing heterotrophic bacteria at and below the chemocline of the central Baltic Sea. ISME J (2013) 1.21
Use of bromodeoxyuridine immunocapture to identify active bacteria associated with arbuscular mycorrhizal hyphae. Appl Environ Microbiol (2003) 1.20
Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr (2012) 1.20
DNA-level characterization of Helicobacter pylori strains from patients with overt disease and with benign infections in Bangladesh. J Clin Microbiol (2003) 1.18
Which sequencing depth is sufficient to describe patterns in bacterial α- and β-diversity? Environ Microbiol Rep (2012) 1.16
Free-living amoebae promote growth and survival of Helicobacter pylori. Scand J Infect Dis (2002) 1.15
Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res (2011) 1.14
Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol (2008) 1.14
Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin. Emerg Infect Dis (2005) 1.10
Strategies for metagenomic-guided whole-community proteomics of complex microbial environments. PLoS One (2011) 1.09
Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione. FASEB J (2012) 1.09
An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection. Proc Natl Acad Sci U S A (2006) 1.09
Novel 4-chlorophenol degradation gene cluster and degradation route via hydroxyquinol in Arthrobacter chlorophenolicus A6. Appl Environ Microbiol (2005) 1.08
Chitinase genes revealed and compared in bacterial isolates, DNA extracts and a metagenomic library from a phytopathogen-suppressive soil. FEMS Microbiol Ecol (2009) 1.08
Metagenomic de novo assembly of an aquatic representative of the verrucomicrobial class Spartobacteria. MBio (2013) 1.07
Uptake and replication of Salmonella enterica in Acanthamoeba rhysodes. Appl Environ Microbiol (2004) 1.06
Genome sequencing reveals a phage in Helicobacter pylori. MBio (2011) 1.05
Freshwater bacterioplankton richness in oligotrophic lakes depends on nutrient availability rather than on species-area relationships. ISME J (2011) 1.05
Comparative analysis of the complete cag pathogenicity island sequence in four Helicobacter pylori isolates. Gene (2004) 1.04
Omics for understanding microbial functional dynamics. Environ Microbiol (2011) 1.04
Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol (2004) 1.03
In vivo study of trichoderma-pathogen-plant interactions, using constitutive and inducible green fluorescent protein reporter systems. Appl Environ Microbiol (2004) 1.03
Combined bromodeoxyuridine immunocapture and terminal-restriction fragment length polymorphism analysis highlights differences in the active soil bacterial metagenome due to Glomus mosseae inoculation or plant species. Environ Microbiol (2005) 1.03
Attachment of different soil bacteria to arbuscular mycorrhizal fungal extraradical hyphae is determined by hyphal vitality and fungal species. FEMS Microbiol Lett (2006) 1.02
Active bacterial community structure along vertical redox gradients in Baltic Sea sediment. Environ Microbiol (2008) 1.02
Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. PLoS One (2008) 1.02
Degradation of mixtures of phenolic compounds by Arthrobacter chlorophenolicus A6. Biodegradation (2007) 1.01
Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother (2003) 0.99
Pyrosequencing Bacillus anthracis. Emerg Infect Dis (2005) 0.99
Microbial community structure in polluted Baltic Sea sediments. Environ Microbiol (2006) 0.99
Slow genetic divergence of Helicobacter pylori strains during long-term colonization. Infect Immun (2005) 0.98
Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases. BMC Public Health (2012) 0.98
Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe (2008) 0.98
Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One (2011) 0.97
Genomic diversity of the 2011 European outbreaks of Escherichia coli O104:H4. Proc Natl Acad Sci U S A (2012) 0.97